Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study

Abstract Background While the process of sepsis-induced immunosuppression is now well described in adults, very little information is available on immune functions in pediatric sepsis. The current study investigated this in children with septic shock by performing immunomonitoring, including both in...

Full description

Bibliographic Details
Main Authors: Solenn Remy, Karine Kolev-Descamps, Morgane Gossez, Fabienne Venet, Julie Demaret, Etienne Javouhey, Guillaume Monneret
Format: Article
Language:English
Published: SpringerOpen 2018-03-01
Series:Annals of Intensive Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13613-018-0382-x
id doaj-19d2a347e9a64405ae5151c779a34727
record_format Article
spelling doaj-19d2a347e9a64405ae5151c779a347272020-11-24T23:56:29ZengSpringerOpenAnnals of Intensive Care2110-58202018-03-018111010.1186/s13613-018-0382-xOccurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot studySolenn Remy0Karine Kolev-Descamps1Morgane Gossez2Fabienne Venet3Julie Demaret4Etienne Javouhey5Guillaume Monneret6Hospices Civils de Lyon, Paediatric Intensive Care Unit, Mother and Children University HospitalHospices Civils de Lyon, Paediatric Intensive Care Unit, Mother and Children University HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalHospices Civils de Lyon, Paediatric Intensive Care Unit, Mother and Children University HospitalHospices Civils de Lyon, Immunology Laboratory, E. Herriot HospitalAbstract Background While the process of sepsis-induced immunosuppression is now well described in adults, very little information is available on immune functions in pediatric sepsis. The current study investigated this in children with septic shock by performing immunomonitoring, including both innate (monocyte human leukocyte antigen-DR, mHLA-DR, expression) and adaptive immunity (lymphocyte subsets count), as well as cytokine concentrations (IL-6, IL-8, IL-10, IL-1Ra, TNF-α, IFN-γ). Subsequent objectives were to assess the associations between inflammatory response, potential immunosuppression and secondary acquired infection occurrence. Methods Single-center prospective observational study, including children aged between 1 month and 18 years admitted to pediatric intensive care unit (PICU) for septic shock. Age-matched controls were children hospitalized for elective surgery without any infectious criteria. Blood was sampled at day 1–2, 3–5, and 7–9 after sepsis onset. mHLA-DR and lymphocyte subsets count were measured by flow cytometry and cytokine concentrations by Luminex technology. Results A total of 26 children and 30 controls were included. Patients had lymphopenia, and mHLA-DR levels were significantly lower than controls at each time point (p < 0.0001). All cytokines peaked at day 1–2. Children with secondary acquired infection had lower day 3–5 mHLA-DR and higher pro-inflammatory cytokine concentrations (IL-6, IL-8 and TNF-α) at day 1–2 compared to children without secondary acquired infection. Conclusions The higher initial inflammatory cytokine production was, the more innate immunity was altered, while evaluated by low mHLA-DR expression. Children with decreased mHLA-DR expression developed more secondary acquired infections. Upon confirmation in multicenter cohorts, these results pave the way for immunostimulation for the most immunosuppressed children in order to prevent nosocomial infections in PICU. Trial registration PedIRIS study NCT02848144. Retrospectively registered 28 July 2016http://link.springer.com/article/10.1186/s13613-018-0382-xSeptic shockImmunosuppression inducedChildren
collection DOAJ
language English
format Article
sources DOAJ
author Solenn Remy
Karine Kolev-Descamps
Morgane Gossez
Fabienne Venet
Julie Demaret
Etienne Javouhey
Guillaume Monneret
spellingShingle Solenn Remy
Karine Kolev-Descamps
Morgane Gossez
Fabienne Venet
Julie Demaret
Etienne Javouhey
Guillaume Monneret
Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
Annals of Intensive Care
Septic shock
Immunosuppression induced
Children
author_facet Solenn Remy
Karine Kolev-Descamps
Morgane Gossez
Fabienne Venet
Julie Demaret
Etienne Javouhey
Guillaume Monneret
author_sort Solenn Remy
title Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
title_short Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
title_full Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
title_fullStr Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
title_full_unstemmed Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
title_sort occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study
publisher SpringerOpen
series Annals of Intensive Care
issn 2110-5820
publishDate 2018-03-01
description Abstract Background While the process of sepsis-induced immunosuppression is now well described in adults, very little information is available on immune functions in pediatric sepsis. The current study investigated this in children with septic shock by performing immunomonitoring, including both innate (monocyte human leukocyte antigen-DR, mHLA-DR, expression) and adaptive immunity (lymphocyte subsets count), as well as cytokine concentrations (IL-6, IL-8, IL-10, IL-1Ra, TNF-α, IFN-γ). Subsequent objectives were to assess the associations between inflammatory response, potential immunosuppression and secondary acquired infection occurrence. Methods Single-center prospective observational study, including children aged between 1 month and 18 years admitted to pediatric intensive care unit (PICU) for septic shock. Age-matched controls were children hospitalized for elective surgery without any infectious criteria. Blood was sampled at day 1–2, 3–5, and 7–9 after sepsis onset. mHLA-DR and lymphocyte subsets count were measured by flow cytometry and cytokine concentrations by Luminex technology. Results A total of 26 children and 30 controls were included. Patients had lymphopenia, and mHLA-DR levels were significantly lower than controls at each time point (p < 0.0001). All cytokines peaked at day 1–2. Children with secondary acquired infection had lower day 3–5 mHLA-DR and higher pro-inflammatory cytokine concentrations (IL-6, IL-8 and TNF-α) at day 1–2 compared to children without secondary acquired infection. Conclusions The higher initial inflammatory cytokine production was, the more innate immunity was altered, while evaluated by low mHLA-DR expression. Children with decreased mHLA-DR expression developed more secondary acquired infections. Upon confirmation in multicenter cohorts, these results pave the way for immunostimulation for the most immunosuppressed children in order to prevent nosocomial infections in PICU. Trial registration PedIRIS study NCT02848144. Retrospectively registered 28 July 2016
topic Septic shock
Immunosuppression induced
Children
url http://link.springer.com/article/10.1186/s13613-018-0382-x
work_keys_str_mv AT solennremy occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
AT karinekolevdescamps occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
AT morganegossez occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
AT fabiennevenet occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
AT juliedemaret occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
AT etiennejavouhey occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
AT guillaumemonneret occurrenceofmarkedsepsisinducedimmunosuppressioninpediatricsepticshockapilotstudy
_version_ 1725458308666490880